We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hamburg: Flexible Enforcement Is an FDA Priority
Hamburg: Flexible Enforcement Is an FDA Priority
May 3, 2010
The FDA is pursuing more flexible enforcement mechanisms to handle situations such as the recent contamination of GlaxoSmithKline’s (GSK) pediatric
Rotarix vaccine, Commissioner Margaret Hamburg says.